Investing Profile

Clay Thorp

InvestorVC
General Partner at Hatteras Venture Partners
hatterasvp.comChapel Hill, North Carolina
Photo of Clay Thorp, General Partner at Hatteras Venture Partners
Your Intro Paths to Clay Thorp
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Clay Thorp on

cb
Current Investing Position
Hatteras Venture Partners General Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
12
Current Fund Size
$94M

Clay Thorp is on these Sector & Stage Rankings

Clay Thorp's Investments On Record (9)

CompanyStageDateRound SizeTotal Raised
Myeloid Therapeutics
Series AMay 2023$73M
$73M
Ten63 Therapeutics
Series AMay 2023$16M
$16M
Co-investors: Arvind Gupta (Mayfield), Po Bronson (SOSV), Damien Petty (Morpheus Ventures)
Rodin Therapeutics
Series CSep 2017$27M
$64M
Co-investors: Ben Robbins (GV (Google Ventures)), Bruce Booth (Atlas Venture), Martin Alexander Gershon (Endeavor Venture Funds)
Lysosomal Therapeutics
Series AFeb 2015$20M
SeedMay 2014$5M
$25M
Co-investors: Reza Halse (RA Capital), Bernard Davitian (Omega Funds), Carole Nuechterlein (Roche Venture Fund), Bruce Booth (Atlas Venture)
Clearside Biomedical
Series BSep 2014$16M
Series AFeb 2013$8M
Series AJan 2012$4M
$28M
Co-investors: Christy Shaffer (Hatteras Venture Partners)
Curoverse
SeedDec 2013$2M
$2M
Co-investors: David Martirano (Point Judith Capital)
Pathfinder Therapeutics
Series AOct 2008$5M
$5M
ArtusLabs
Series AJun 2008$3M
$3M